Originally published In Press as doi:10.1074/jbc.M112080200 on March 29, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20234-20242, June 7, 2002
Direct, Ca2+-dependent Interaction
between Tubulin and Synaptotagmin I
A POSSIBLE MECHANISM FOR ATTACHING SYNAPTIC VESICLES TO
MICROTUBULES*
Atsuko
Honda
§¶,
Mitsunori
Yamada
,
Hideo
Saisu
,
Hitoshi
Takahashi
,
Kazuhiro J.
Mori§, and
Teruo
Abe
**
From the Departments of
Cellular Neurobiology and
Pathology, Brain Research Institute and the
§ Department of Biology, Faculty of Science, Niigata
University, Niigata 951-8585, Japan
Received for publication, December 18, 2001, and in revised form, March 25, 2002
 |
ABSTRACT |
The synaptic vesicle protein synaptotagmin I
probably plays important roles in the synaptic vesicle cycle. However,
the mechanisms of its action remain unclear. In this study, we have
searched for cytoplasmic proteins that interact with synaptotagmin I. We found that the cytoskeletal protein tubulin directly and
stoichiometrically bound to recombinant synaptotagmin I. The binding
depended on mM Ca2+, and 1 mol of
tubulin dimer bound 2 mol of synaptotagmin I with half-maximal binding
at 6.6 µM tubulin. The Ca2+ dependence mainly
resulted from Ca2+ binding to the Ca2+ ligands
of synaptotagmin I. The C-terminal region of
-tubulin and both C2
domains of synaptotagmin I were involved in the binding. The YVK motif
in the C2 domains of synaptotagmin I was essential for tubulin binding.
Tubulin and synaptotagmin I were co-precipitated from the synaptosome
extract with monoclonal antibodies to tubulin and SNAP-25
(synaptosome-associated protein of 25 kDa), indicating the presence of
tubulin/synaptotagmin I complex and tubulin binding to synaptotagmin I
in SNARE (soluble N-ethylmaleimide-sensitive factor
attachment protein receptor) complexes. Synaptotagmin I promoted
tubulin polymerization and bundled microtubules in the presence of
Ca2+. These results suggest that direct interaction between
synaptotagmin I and tubulin provides a mechanism for attaching synaptic
vesicles to microtubules in high Ca2+ concentrations.
 |
INTRODUCTION |
Chemical synapses depend on fast release of neurotransmitter
molecules from the presynaptic terminal by synaptic vesicle exocytosis (1). This release is triggered by instantaneous increase of intracellular Ca2+ concentration around the release site
(active zone), due to Ca2+ influx through voltage-sensitive
calcium channels opened by depolarization. After exocytosis, synaptic
vesicles are rapidly endocytosed and regenerated by multiple pathways.
Synaptic vesicle endocytosis is a process driven by concerted actions
of many proteins and other substances, which is not yet fully
understood (2, 3). Thus synaptic vesicles undergo a complex, tightly
regulated cycle. To understand the mechanisms of the synaptic
plasticity underlying higher brain functions, it is essential to
elucidate the molecular basis of this synaptic vesicle cycle.
Recent investigations have established a central role of
SNAREs1 in the release
process of neurotransmitters; specific interactions between t-SNAREs
(syntaxin and SNAP-25 from the presynaptic membrane) and a v-SNARE
(VAMP/synaptobrevin from the synaptic vesicle membrane) are critical
for synaptic vesicle exocytosis (4-7). This trans-SNARE complex forms a parallel four-helix bundle (8-10). Close apposition of
the synaptic vesicle membrane and the presynaptic membrane by the tight
trans-SNARE complex, with the energy released by its
assembly, is proposed to drive fusion between the two membranes (11).
The complex may serve as a minimal machinery for membrane fusion as
supported by liposome fusion (12). However, many important aspects of
the synaptic vesicle cycle still remain unclear. For instance, how does
Ca2+ trigger a cascade of interactions between the SNAREs?
How can selective retrieval of the synaptic vesicle membrane from the plasma membrane be achieved? How are endocytosed synaptic vesicles distributed into different pools?
Synaptotagmin I is a Ca2+-binding, synaptic vesicle
membrane protein that probably plays important roles in the synaptic
vesicle cycle (13-15). The protein consists of a short N-terminal
luminal domain, one transmembrane segment, and two C2 domains extending into the cytoplasm. In vitro, these C2 domains bind
Ca2+ (15), phospholipids (16-18), syntaxin 1 (19-20), and
SNAP-25 (21, 22). The protein forms complexes with SNAREs including VAMP through its Ca2+-dependent binding to
syntaxin 1 and SNAP-25. The Ca2+ affinity of its binding to
syntaxin 1 and SNAP-25 apparently matches that of neurotransmitter
release (23). Synaptotagmin mutants exhibit severe movement disorders
in the nematode Caenorhabditis elegans (24) and a marked
decrease of Ca2+-dependent neurotransmitter
release in Drosophila (25, 26). In synaptotagmin I-deficient
mice, fast neurotransmitter release is profoundly impaired (27),
suggesting an important role of the protein in the release mechanisms.
A very recent genetic study has shown a quantitative relationship
between the Ca2+-binding affinity of synaptotagmin I and
the Ca2+ sensitivity of transmitter release (28).
Furthermore, the protein responds to Ca2+ very rapidly to
bind simultaneously to membrane and the ternary SNARE complex (29).
Based on these findings, the protein has been widely assumed as a major
Ca2+ sensor in the release process. However, it remains to
be elucidated how synaptotagmin I could transmit the Ca2+
signal to the SNAREs, eventually bringing about the fusion of the
synaptic vesicle membrane with the presynaptic membrane. Interestingly, overexpression of synaptotagmin I in PC12 cells modulated fusion pore
kinetics, indicating its interaction with fusion pores (30).
The protein also interacts with the clathrin adaptor protein AP-2 with
high affinity (31, 32), suggesting its involvement in synaptic vesicle
endocytosis. In synaptotagmin mutants of C. elegans
(33) and Drosophila (34), synaptic vesicles in the nerve
terminal were markedly decreased. A similar decrease of synaptic
vesicles was observed in the squid nerve terminal injected with a
polyclonal antibody to synaptotagmin I (35). Moreover, overexpression
of synaptotagmin I or II in the neuromuscular junction of
Xenopus led to a different distribution of synaptic vesicles without change in the total number of synaptic vesicles (36). These
findings suggest that synaptotagmin I is involved not only in the
endocytosis of synaptic vesicles but also in their distribution. The
protein thus seems to regulate many steps of the synaptic vesicle
cycle. However, its exact role in each step remains poorly understood.
To understand the mechanisms of various functions of synaptotagmin I,
we searched for cytosolic proteins that interact with synaptotagmin I. We have found that synaptotagmin I directly binds to tubulin in a
Ca2+-dependent manner. Our findings suggest
that this binding provides a mechanism for attaching synaptic vesicles
to microtubules in high Ca2+ concentrations. Preliminary
accounts of this work have been published (37, 38).
 |
EXPERIMENTAL PROCEDURES |
Materials--
Taxol, subtilisin (type III),
phenylmethylsulfonyl fluoride AEBSF, bovine thrombin, and
benzamidine-agarose were purchased from Sigma. Glutathione-Sepharose
and protein G-Sepharose fast flow were obtained from Amersham Biosciences.
Antibodies--
Anti-
-tubulin and
-tubulin mAbs (DM1A and
TUB 2.1, respectively) were obtained from Sigma. Anti-SNARE mAbs have
been reported previously (39). A polyclonal antibody against rat VAMP-2
was generated by immunizing BALB/c mice with recombinant, full-length VAMP-2 prepared by digestion of GST-VAMP-2 with thrombin. One hundred
µg (first injection) or 50 µg (subsequent injections) of VAMP-2 in
phosphate-buffered saline was emulsified with an equal volume of
Freund's complete (first injection) or incomplete (subsequent
injections) adjuvant and injected intraperitoneally at two-week
intervals. One week after the fourth injection, mouse antisera were
collected. A mAb (3F10) raised against the N-terminal region of
synaptotagmin I (40) was a gift from M. Takahashi (Mitsubishi Kasei
Institute for Life Sciences, Tokyo, Japan).
Subcellular Fractions--
All procedures were carried out at
4 °C in the presence of protease inhibitors (1 µM
pepstatin A/2 µM leupeptin/0.3 mM
phenylmethylsulfonyl fluoride). Fresh forebrains from three-week-old
female rats were homogenized in 10 mM Hepes-NaOH (pH 7.4),
and then solid NaCl was added to a final concentration of 150 mM. After incubation for 30 min, the homogenate was
centrifuged at 200,000 × g for 1 h, and the
supernatant was used as the soluble fraction. The lysed P2 and crude
synaptosome fractions were prepared from adult rat forebrains as
follows. Forebrains were homogenized in 10 mM Hepes-NaOH
(pH 7.4)/0.32 M sucrose and centrifuged at 700 × g for 10 min. The supernatant was centrifuged again at
9000 × g for 20 min, and the pellet (P2 fraction) was
collected as crude synaptosome fraction. The P2 fraction was lysed by
dilution into 9 volumes of 10 mM Hepes-NaOH (pH 7.4) and
incubated for 30 min. The pellet obtained by centrifugation at
9000 × g for 20 min was the lysed P2 fraction. The
lysed P2 and crude synaptosome fractions were suspended in solution A
(20 mM Hepes-NaOH (pH 7.4)/150 mM NaCl) at a
protein concentration of 4 mg/ml, and equal volumes of solution A
containing 2% (w/v) Triton X-100 were added. The mixtures were stirred
for 30 min and then centrifuged at 100,000 × g for
1 h. The resultant supernatants were diluted with equal volumes of
solution A and used as the Triton X-100 extracts. These extracts were
used immediately after preparation. Protein concentrations were
determined using the Bio-Rad protein assay kit.
Expression and Purification of GST Fusion
Proteins--
cDNAs for full-length and cytoplasmic regions of
wild-type or mutant rat synaptotagmin I were prepared by PCR and cloned
into the pGEX-KG vector to express as GST fusion proteins. Substituted mutations of constituents of the Ca2+ ligand
(D230N/D232N and D363N/D365N), the polylysine motifs
(K(189-192)A and K(324-327)A) or the (SDP) YVK motifs
(Y180A/V181A/K182A and Y311A/V312A/K313A) were prepared using the
overlapping primer method (41). Plasmids for GST fusion proteins of the
cytoplasmic regions of rat syntaxin 1A and VAMP-2 and full-length mouse
SNAP-25 were similarly prepared. All constructs were verified by DNA
sequencing. These constructs were transfected to the Escherichia
coli strain BL21. GST fusion proteins were purified using
glutathione-Sepharose. For some experiments, GST-synaptotagmin I bound
to glutathione-Sepharose was cleaved with thrombin (1 unit/mg GST
fusion protein). Thrombin in the released proteins was removed with
benzamidine-agarose. All recombinant proteins were used within 3 days
after purification.
Affinity Chromatography on GST Fusion Proteins--
GST alone,
GST-entire cytoplasmic portion of synaptotagmin I (referred to as
GST-synaptotagmin I), or GST-synaptotagmin I fragments (all 3 µM) immobilized on glutathione-Sepharose beads (100 µl)
were incubated with the rat brain-soluble fraction (1 mg of protein/ml)
or purified tubulin (1 mg/ml) in 0.5% Triton X-100/HNa buffer (10 mM Hepes-NaOH (pH 7.4)/150 mM NaCl/1
µM pepstatin A/2 µM leupeptin/0.3
mM phenylmethylsulfonyl fluoride) containing 3 mM CaCl2 or 1 mM EGTA for 2 h
at 4 °C. The beads were then washed three times with 1 ml of 0.1%
Triton X-100/HNa buffer containing 3 mM CaCl2
or 1 mM EGTA. The bound materials were eluted with the
sample buffer (42) and subjected to SDS-PAGE.
Affinity Chromatography on Tubulin-Sepharose--
Purified
tubulin (see below) was coupled to CNBr-activated Sepharose 4B
(Amersham Biosciences) (1.1 mg of tubulin/ml gel). Tubulin-Sepharose
beads were incubated with the Triton X-100 extract of the lysed P2
fraction (1 mg of protein/ml in 0.5% Triton X-100/HNa buffer/3
mM CaCl2) for 2 h at 4 °C. The beads
were washed three times with 10 volumes of 0.5% Triton X-100/HNa
buffer/3 mM CaCl2 and then with 10 volumes of
0.1% Triton X-100/HNa buffer/3 mM CaCl2. The
bound materials were eluted with the sample buffer, fractionated by
SDS-PAGE, and detected by immunoblotting.
Purification and Subtilisin Treatment of Tubulin--
Whole
microtubule proteins (CS3) were prepared from porcine brains by
temperature-dependent cycles of assembly-disassembly following the procedures of Shelanski et al. (43). Pure
tubulin was isolated from CS3 by chromatography on phosphocellulose
(Whatman P-11) (44), concentrated by ultrafiltration to 10 mg/ml, and stored at
80 °C until use. Digestion of tubulin with subtilisin was carried out by modifying the method of Rodionov et al.
(45). Briefly, taxol-stabilized microtubules (10 mg/ml tubulin treated with 20 µM taxol) were digested with subtilisin (10 µg/ml) for 15 min or overnight at 37 °C. The cleavage reactions
were terminated by addition of 2 mM AEBSF.
Subtilisin-treated microtubules were sedimented through a cushion of
10% (w/v) sucrose in RB buffer (100 mM Mes-KOH (pH
6.8)/0.5 mM MgCl2/1 mM EGTA)
containing 1 mM GTP, 20 µM taxol, and 2 mM AEBSF at 100,000 × g for 50 min at
30 °C. The pellets were washed and resuspended in HNa buffer containing 2 mM AEBSF. The subtilisin-digested tubulins
were subjected to SDS-PAGE by the modified Laemmli's method (46).
Blot Overlay Assay--
Purified tubulin was resolved by
SDS-PAGE on 12.5% gel and transferred to nitrocellulose membrane. The
membrane was blocked overnight at 4 °C with 3% skim milk in TBST
buffer (0.05% Tween 20/10 mM Tris-HCl (pH 8.0)/150
mM NaCl) and then incubated for 6 h with the Triton
X-100 extract of the lysed P2 fraction (final protein concentration of
1 mg/ml in 0.5% Triton X-100/HNa buffer/3 mM
CaCl2). After washing five times with TBST/3 mM
CaCl2, synaptotagmin I bound to tubulins was detected by a
mAb to the protein.
Immunoprecipitation--
Protein G-Sepharose fast flow (250 µl
of resin) was incubated with a mAb to
-tubulin (DM1A) or mAb to
SNAP-25 (6H4, see Ref. 39) for 2 h and then washed three times
with 0.2 M borate buffer (pH 9.0). Solid dimethyl
pimelimidate was added to a final concentration of 20 mM,
and the mixture was incubated for 45 min at room temperature. Then the
Sepharose beads were washed twice and incubated for 2 h in 0.2 M ethanolamine-HCl (pH 8.0). The mAb-coupled Sepharose beads were rinsed in phosphate-buffered saline and stored at 4 °C.
Tubulin and SNAP-25 were immunoprecipitated from 2 ml of the Triton
X-100 extract (1 mg of protein/ml) of crude synaptosomes by incubating
with 50 µl of mAb-coupled protein G-Sepharose for 2 h at
4 °C. The resin was washed three times with 10 volumes of HNa
buffer/0.1% Triton X-100. The proteins precipitated with the resin
were eluted with the sample buffer, fractionated by SDS-PAGE, and
detected by immunoblotting using the ECL Western blotting detection
reagents (Amersham Biosciences).
Measurement of Tubulin Polymerization--
CS3 (2 mg/ml) or a
mixture of thrombin-released synaptotagmin I (1.5 µM) and
CS3 was incubated in the presence or absence of 1 mM
CaCl2 for 30 min at 4 °C and transferred to cuvettes. The cuvettes were warmed to 37 °C, and 1 mM GTP was
added. Microtubule formation was assayed by measuring turbidity
(absorbance at 340 nm) at 37 °C. Aliquots of polymerization
reactions taken at 30 min at 37 °C were analyzed by electron microscopy.
Co-sedimentation of Synaptotagmin I and Tubulin--
A mixture
of CS3 and thrombin-released synaptotagmin I was incubated for 30 min
at 30 °C in the presence of 1 mM GTP and 1 mM CaCl2 and then centrifuged at 100,000 × g for 50 min at 30 °C through a cushion of 10%
sucrose in RB buffer without EGTA. The pellet was homogenized on ice in
RB buffer/1 mM GTP/1 mM CaCl2 and
then centrifuged at 100,000 × g for 50 min at 4 °C.
Coomassie Blue staining after SDS-PAGE detected proteins in each
supernatant and pellet.
Electron Microscopy--
Samples were applied to
collodion-coated grids (400 mesh) for 30 s and then fixed with 1%
(w/v) glutaraldehyde for 5 s. After rinses in distilled water,
samples were negatively stained with 3% (w/v) uranyl acetate solution.
The grids were examined with the Hitachi H-7100 electron microscope.
 |
RESULTS |
Binding of Tubulin to Synaptotagmin I--
To identify soluble
proteins that specifically interact with synaptotagmin I, the soluble
fraction from the rat brain was incubated with GST fusion protein of
the cytoplasmic portion of synaptotagmin I immobilized on
glutathione-Sepharose. After thorough washing, the bound materials were
eluted with SDS and subjected to SDS-PAGE. When the soluble fraction
was incubated with GST-synaptotagmin I in the presence of EGTA, no
major binding components were detected. (data not shown). However, in
the presence of 3 mM CaCl2, only a protein of
55 kDa was found in the bound material (Fig.
1a). This component was not
retained by immobilized GST alone (Fig. 1b), GST fusion
proteins of the cytoplasmic portion of syntaxin 1A or VAMP-2, or
full-length SNAP-25 (data not shown), indicating the specificity of the
binding. The 55-kDa protein was recognized by mAbs specific to
- or
-tubulin (Fig. 1b). Based on the molecular mass value and
the reaction with the mAbs, the 55-kDa band was identified as a mixture
of
- and
-tubulin.

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 1.
Binding of tubulin to synaptotagmin I. a, GST-synaptotagmin I (syt) interacts with the 55-kDa
protein. GST-synaptotagmin I immobilized on glutathione-Sepharose was
incubated with the brain soluble fraction in 3 mM
CaCl2 for 2 h at 4 °C. Bound proteins were eluted
with the sample buffer and resolved by SDS-PAGE (12.5% gel). Proteins
were stained with Coomassie Blue. Lane 1, proteins in the
brain soluble fraction. Twenty-five µg of protein was loaded;
lane 2, GST-synaptotagmin I only; lane 3,
GST-synaptotagmin I incubated with the brain-soluble fraction. The
position of GST-synaptotagmin I and molecular mass values of marker
proteins are shown. The asterisk indicates the 55-kDa
protein. b, immunoblots of GST-synaptotagmin I-binding
proteins with anti-tubulin mAbs. Proteins bound to GST alone or
GST-synaptotagmin I was fractionated by SDS-PAGE (7.5% gel) and
immunoblotted with anti- - and -tubulin mAbs. GST: lane
1, Amido Black 10B staining of proteins; lane 2, probed
with a mixture of anti- - and -tubulin mAbs. GST-syt:
lane 1, Amido Black 10B staining of proteins; lanes
2 and 3, probed with an anti- - and -tubulin mAbs,
respectively. The positions of - and -tubulin are shown.
|
|
Ca2+ Dependence of the Binding--
To characterize
tubulin binding to synaptotagmin I in more detail, we used purified
tubulin instead of the brain-soluble fraction. We determined tubulin
binding as the molar ratio between synaptotagmin I and tubulin dimer
(
) (usual form of tubulin) by NIHImage analysis of Coomassie
Blue-stained bands. Concentration dependence of tubulin binding to
synaptotagmin I was determined by incubating immobilized GST-synaptotagmin I with increasing concentrations of purified tubulin
in the presence or absence of CaCl2 (Fig.
2a). Purified tubulin
efficiently bound to GST-synaptotagmin I in the presence of
CaCl2. Thus the interaction between GST-synaptotagmin I and tubulin was direct. The binding was saturated at 1.5 mg/ml tubulin with
half-maximal binding at ~6.6 µM (0.72 mg/ml). At the
saturation, the molar ratio between tubulin dimer and synaptotagmin I
was ~0.5, indicating that one tubulin dimer binds two synaptotagmin I
molecules. In the absence of CaCl2, the maximal binding was about one-fifth of that in CaCl2. Fig. 2b
illustrates the Ca2+ dependence of tubulin (2 mg/ml)
binding to synaptotagmin I. Tubulin binding was saturated at 2.0 mM CaCl2 with half-maximal binding at ~0.9
mM CaCl2.
Ca2+-dependent binding of tubulin to
synaptotagmin I appeared to consist of at least two components with
different Ca2+ affinities (see the curve in Fig.
2b), like syntaxin 1A binding to synaptotagmin I (19).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Binding of purified tubulin to synaptotagmin
I. a, concentration dependence. Increasing amounts of
purified tubulin were incubated with 3 µM immobilized
GST-synaptotagmin I for 2 h at 4 °C in the presence of 3 mM CaCl2 or 1 mM EGTA, and bound
tubulin (expressed as mol of tubulin dimer bound/mol of
GST-synaptotagmin I) was determined by NIHImage after Coomassie Blue
staining of SDS gels. b, Ca2+ dependence.
Immobilized GST-synaptotagmin I was incubated with purified tubulin (2 mg/ml) in various concentrations of CaCl2. Another
experiment gave essentially the same results. The inset
shows bound tubulin in the presence of 3 mM
CaCl2 (+) or 1 mM EGTA ( ). Proteins were
stained with Coomassie Blue after SDS-PAGE on 7.5% gel.
|
|
Domain of Synaptotagmin I Involved in Tubulin Binding--
To
determine the domain of synaptotagmin I involved in tubulin binding,
binding of purified tubulin to GST fusion proteins of various portions
of the cytoplasmic domain of synaptotagmin I was examined (Figs.
3, a and b).
Neither the region between the transmembrane segment and the C2A domain
(fragment I) nor the short linker domain between the C2A and C2B
domains (fragment III) exhibited significant binding. Binding of C2A
and C2B domains was respectively about one-half of that of the entire
cytoplasmic domain. C2A domain plus C2B domain without the linker bound
tubulin almost as efficiently as the entire cytoplasmic domain (data
not shown). Therefore, both C2A and C2B domains are involved in tubulin binding.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Domains of synaptotagmin I involved in
tubulin binding. Purified tubulin was incubated with immobilized
GST fusion proteins of various mutants or truncated cytoplasmic
portions of synaptotagmin I and Coomassie Blue staining after SDS-PAGE
detected bound tubulin. a, motifs and fragments of
synaptotagmin I used for binding experiments. Asterisks
indicate the positions of the four aspartic acid residues replaced with
alanine (see d). b, tubulin binding to fragments
of synaptotagmin I. Fragments used are: I, highly charged sequence
region; II, C2A domain; III, short linker region; and IV, C2Bdomain
plus C-terminal region. Each GST fusion protein was incubated with
tubulin in 3 mM CaCl2. Major bands besides
tubulin represent GST fusion proteins used. c, YVK motif is
essential for tubulin binding. GST fusion proteins of wild type and
mutants for the polylysine (KKKK/AAAA) (poly K/A) and YVK
(YVK/AAA) motifs were incubated with tubulin in 3 mM
CaCl2. d, decreased Ca2+ dependence
of tubulin binding in a Ca2+-ligand mutant. GST fusion
proteins of wild-type (WT) or a Ca2+-ligand
mutant (D230N/D232N and D363N/D365N) (D/N) of
synaptotagmin I was incubated with tubulin in 3 mM
CaCl2 (+) or 1 mM EGTA ( ) for 2 h at
4 °C. Bound tubulin was detected by Coomassie Blue staining.
e, summary of tubulin binding to various mutants of
synaptotagmin I in 3 mM CaCl2 or 1 mM EGTA. Results are expressed as means ± S.E.
(n = 3-4). Asterisks indicate
p < 0.001 by Student's t test.
|
|
Based on these findings, we inferred that the sequences common to both
C2 domains of synaptotagmin I might be important for tubulin binding.
We focused on the polylysine (KKKK) (47) and YVK (also called SDPYVK)
(16, 17) motifs conserved between the two C2 domains. In a previous
study, replacement of the polylysine motif with alanine did not impair
syntaxin/synaptotagmin I binding but inhibited neurotransmitter release
from PC12 cells (48). The YVK motif has been shown to be involved in
its Ca2+-dependent binding to syntaxin 1 and
phospholipids (16, 17). We replaced these two motifs in both C2 domains
with alanine and examined tubulin binding of these mutants (Fig.
3c). Although the polylysine motif mutant exhibited normal
binding, binding was negligible in the YVK motif mutant (Fig. 3,
d and e). Thus the YVK motif was essential for
tubulin binding. Tubulin binding in the absence of CaCl2
was also greatly decreased.
Four aspartic acid residues in the C2A (Asp-230 and Asp-232) (15) and
C2B domains (Asp-363 and Asp-365) (49) are important constituents of
the Ca2+-binding sites (Ca2+ ligands) of
synaptotagmin I. Replacement of all these residues with alanine leads
to a loss of Ca2+ sensitivity of the bindings of SNAREs
(syntaxin 1A and SNAP-25) and phospholipids (50). To examine whether
tubulin binding to synaptotagmin I depends on Ca2+
sensitivity of synaptotagmin I as reported for these substances, we
prepared the same mutant. Ca2+-dependent
tubulin binding of the mutant synaptotagmin I was markedly decreased
(38% of wild-type). In contrast, Ca2+-independent binding
did not significantly change (Fig. 3, d and e).
Thus Ca2+ dependence of tubulin binding to synaptotagmin I
mainly results from Ca2+ binding to the Ca2+
ligands of synaptotagmin I.
Tubulin Binds to Synaptotagmin I in SNARE Complexes--
The above
results have shown that tubulin, like some SNAREs,
Ca2+-dependently binds to synaptotagmin I. This
raises the possibility that these SNAREs and tubulin compete for
synaptotagmin I. To check the possibility we immunoprecipitated the
tubulin/synaptotagmin I complex from the Triton X-100 extract of crude
synaptosomes with mAbs to tubulin and the t-SNARE SNAP-25. An
anti-synaptotagmin I mAb precipitated tubulin and SNAREs as well as
synaptotagmin I, showing that the synaptotagmin I/tubulin complex
exists (data not shown). However, this does not tell whether tubulin
and SNAREs compete for synaptotagmin I as synaptotagmin I could bind
SNARE complexes and tubulin, separately. We therefore used an
anti-SNAP-25 mAb as SNAP-25 does not directly bind tubulin (see above).
The immunoprecipitate obtained with a mAb to tubulin contained
synaptotagmin I, syntaxin 1, and SNAP-25 in addition to tubulin (Fig.
4a). Conversely, an
anti-SNAP-25 mAb precipitated tubulin and synaptotagmin I together with
the SNAREs (syntaxin 1, SNAP-25, and VAMP-2) (Fig. 4b).
Practically all of the syntaxin 1 immunoprecipitated with a mAb to
SNAP-25 existed as the ternary complex as shown by SDS resistance at
37 °C. As already mentioned, GST-syntaxin 1A, -SNAP-25, or -VAMP-2 did not bind to tubulin. A previous study has reported a very weak
binding between tubulin and syntaxin 1A (51). However, as the molar
ratio (tubulin to syntaxin 1A) of the binding is about 0.02, it is very
unlikely that syntaxin 1A/tubulin binding significantly contributed to
the immunoprecipitates. Thus immunoprecipitation of synaptotagmin I
with a mAb to tubulin probably indicates the presence of
tubulin/synaptotagmin I binding in vivo. The immunoprecipitation experiments also show that SNAREs and tubulin do not compete with each
other for synaptotagmin I. This conclusion was supported by the finding
that purified tubulin-conjugated Sepharose bound SNARE/synaptotagmin I
complexes present in the Triton X-100 extract of the lysed P2 fraction
(Fig. 4c).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Immunoprecipitation of synaptotagmin
I/tubulin complex from brain synaptosomes. a,
precipitation with a mAb to tubulin. b, precipitation with a
mAb to SNAP-25. The Triton X-100 extract of synaptosomes was
immunoprecipitated, and the precipitated proteins were detected by
immunoblots. a, synaptotagmin I (syt), syntaxin 1 (syn 1), and SNAP-25 were precipitated besides tubulin with
a mAb to tubulin. VAMP-2 was undetectable, probably because of the
small amount precipitated. None of these proteins were detected in the
precipitate with normal mouse IgG (nor. mouse IgG).
b, the precipitate obtained with a mAb to SNAP-25 was
incubated in the sample buffer for 5 min at 95 or 37 °C, subjected
to SDS-PAGE, and then blotted. The blots were incubated with a mixture
of antibodies to synaptotagmin I, tubulin, syntaxin 1, SNAP-25, and
VAMP-2 (left lane) or with a mAb to syntaxin 1 (right
lane). Note that practically all of the syntaxin 1 precipitated
existed as the ternary complex (indicated by an asterisk).
c, binding of SNARE/synaptotagmin I complex to purified
tubulin-conjugated Sepharose. SNAREs and synaptotagmin I were detected
by immunoblotting. The Triton X-100 extract of the lysed P2 fraction
(lane 1) and unbound fraction (lane 2) were
probed with a mixture of mAbs to synaptotagmin I, syntaxin 1, and
SNAP-25. Lanes 3-5, bound fraction was probed with mAbs to
synaptotagmin I, syntaxin 1, and SNAP-25, respectively. Note the
significant decrease of synaptotagmin I in the unbound fraction.
|
|
Domain of Tubulin Involved in Synaptotagmin I Binding--
We next
examined whether one or both of the tubulin dimer subunits were
involved in synaptotagmin I binding by the blot overlay method (Fig.
5a). Purified tubulin
transferred to nitrocellulose membrane was incubated with the Triton
X-100 extract of the lysed P2 fraction, and bound synaptotagmin I was
detected by a mAb.
-Tubulin but not
-tubulin bound synaptotagmin
I. To identify the synaptotagmin I binding domain, purified tubulin was
subjected to limited subtilisin digestion. Short-time digestion of
tubulin dimer with subtilisin is known to remove the C-terminal region of
-tubulin (
s
), and prolonged digestion leads to
the cleavage of
-tubulin as well (
s
s).
Tubulins digested for a short time and overnight were incubated with
immobilized GST-synaptotagmin I, and the bound tubulin was measured
(Fig. 5b). The binding of synaptotagmin I was lost by
removing the C-terminal region of
-tubulin. Taken together, these
results indicate that synaptotagmin I binds to the C-terminal region of
-tubulin.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Synaptotagmin I binds to the C-terminal
region of -tubulin. a, blot
overlay of synaptotagmin I. Purified tubulin was blotted to
nitrocellulose membrane after SDS-PAGE. The blot was incubated for
6 h with the Triton X-100 extract of the lysed P2 fraction in the
presence of 3 mM CaCl2 and washed with TBST
buffer containing 3 mM CaCl2. Bound
synaptotagmin I was detected with a mAb. The left lane shows
protein staining with Amido Black 10B. The positions of - and
-tubulins are shown. b, effects of cleavage of purified
tubulin with subtilisin on its binding to synaptotagmin I. Taxol-treated tubulin was incubated without ( ) or with subtilisin for
15 min (15') or overnight (O/N). The positions of
undigested - and -tubulins, and -tubulin
( s) and -tubulin
( s) deprived of the C-terminal region are
shown. Immobilized GST-synaptotagmin I was incubated with these
tubulins for 2 h at 4 °C, and bound tubulins were detected by
Coomassie Blue staining.
|
|
Facilitation of Tubulin Polymerization by Synaptotagmin I in the
Presence of Ca2+--
Microtubules interact with various
proteins. Microtubule-associated proteins (MAPs) are involved in the
molecular motor or in the regulation of tubulin assembly. The binding
of MAPs to tubulin C termini promotes stabilization and bundling of
microtubules (52). To see whether this is also the case for
synaptotagmin I we examined the effect of synaptotagmin I on tubulin
polymerization by measuring turbidity (absorbance at 340 nm). Tubulin
polymerization was induced by addition of GTP at 30 °C. Fig.
6a illustrates a typical
example of such experiments. In the presence of Ca2+,
turbidity of tubulin alone changed little, indicating very little polymerization, in agreement with the well known inhibition of tubulin
polymerization by Ca2+ (53). Its turbidity steadily
increased in the absence of Ca2+. The co-presence of
wild-type synaptotagmin I increased turbidity more than tubulin alone.
Importantly, unlike tubulin alone, Ca2+ further increased
turbidity. However, when the YVK/AAA mutant of synaptotagmin I was
used, enhancement of tubulin polymerization by Ca2+ was not
observed; Ca2+ strongly inhibited polymerization as in the
case of tubulin alone. This finding is consistent with the poor binding
of the YVK/AAA mutant to tubulin (see Fig. 3). Formation of
microtubules was analyzed by electron microscopy (Fig. 6b).
Compared with normal microtubules in the absence of Ca2+,
those in the presence of Ca2+ were rare, short, and
incompletely assembled. Microtubules tended to be bundled in the
presence of both synaptotagmin I and Ca2+. These results
show that synaptotagmin I facilitated tubulin polymerization and
microtubule bundling in the presence of Ca2+.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6.
Synaptotagmin I promotes tubulin
assembly. a, measurements of tubulin assembly
reactions. CS3 (microtubule protein, 2 mg/ml) alone or CS3 plus the
cytoplasmic domain of synaptotagmin I (wild-type (syt) or YVK/AAA
mutant) in 1 mM CaCl2 (filled
symbols) or 1 mM EGTA (open symbols) was
incubated in a cuvette at 37 °C. After addition of GTP,
polymerization kinetics was measured by monitoring turbidity
(absorbance at 340 nm). b, electron microscopic images of
polymerized tubulins. Samples of CS3 alone in 1 mM EGTA
(open circle in a), CS3 alone in 1 mM
CaCl2 (filled circle), and CS3 plus
synaptotagmin I in 1 mM CaCl2 (filled
triangle) at 30 min after addition of GTP were negatively stained
and examined by electron microscopy. Scale bar = 250 nm.
|
|
Binding of Synaptotagmin I to Microtubules--
The results
described above indicate that synaptotagmin I, like MAPs, can also bind
to microtubules. We determined whether synaptotagmin I/tubulin binding
was present even after tubulin polymerization. For this purpose tubulin
was subjected to polymerization-depolymerization cycles by heat/cold
treatment in the presence of synaptotagmin I (Fig.
7). After polymerization, most
synaptotagmin I was recovered in the pellet (microtubules). After
depolymerization, synaptotagmin I was partially recovered in the
supernatant. Thus synaptotagmin I could bind both free tubulin dimer
and tubulins in microtubules.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 7.
Synaptotagmin I also binds to polymerized
tubulin. Synaptotagmin I co-cycles with tubulin during a cycle of
assembly and disassembly. A mixture of microtubule proteins
(CS3) and the cytoplasmic domain of synaptotagmin
(syt) was incubated in RB buffer without EGTA containing 1 mM GTP and 1 mM CaCl2 for 30 min at
37 °C (indicated by H). Then the mixture was centrifuged
(100,000 × g for 40 min) at 30 °C, and the
resultant supernatant (S) containing free tubulin was saved.
Part of the pellet (P) containing microtubules was
homogenized in the same solution (indicated by C), kept on
ice for 30 min, and centrifuged as above at 4 °C. The supernatant
(S) and the pellet (P) were obtained. The
fractions were analyzed by SDS-PAGE. Left panel, the
proteins used; right panel, protein staining in each
fraction. The positions of tubulin (tub) and synaptotagmin I
are shown.
|
|
 |
DISCUSSION |
The present study has demonstrated direct,
Ca2+-dependent binding of synaptotagmin I to
the cytoskeletal protein tubulin. To our knowledge, this is the first
demonstration of direct interaction between the two proteins. The
existence of synaptotagmin I/tubulin complex in vivo was supported by
its immunoprecipitation from the detergent extract of crude
synaptosomes. The stoichiometry of the binding was two
synaptotagmin I molecules per one tubulin dimer (composed of one
-tubulin and one
-tubulin). Our results indicate that the
C-terminal region of
-tubulin is responsible for synaptotagmin I
binding. Thus the C terminus of
-tubulin may be able to hold two
synaptotagmin I molecules. Alternatively, the C terminus may
preferentially bind a homodimer of synaptotagmin I as synaptotagmin I
oligomerizes (mainly dimers) in the presence of Ca2+ (54,
55).
Our data show that the Ca2+ dependence of the binding
mainly derives from Ca2+ binding to the Ca2+
ligands in both C2 domains of synaptotagmin I, similar to the binding
of syntaxin 1A, SNAP-25, and phospholipids to synaptotagmin I (50).
However, the binding of tubulin needs much higher Ca2+
concentrations. At present, we cannot exclude the possibility that some
factor(s) in the cell greatly increase the Ca2+ sensitivity
of the interaction between tubulin and synaptotagmin I. The reason for
the requirement for high Ca2+ concentrations for the
interaction between tubulin and synaptotagmin I is unclear.
Tubulin/synaptotagmin I interaction may require all the
Ca2+-binding sites in the C2 domains of synaptotagmin I to
be filled with Ca2+; this would need Ca2+
concentrations of >1 mM (15). Binding of phospholipids
increases the apparent affinity for Ca2+ 1000-fold. In
addition, tubulin/synaptotagmin I interaction may require
Ca2+ binding to all the low affinity
Ca2+-binding sites of tubulin, which needs
mM level of Ca2+ (56). Unlike the high affinity
sites (see below), the low affinity Ca2+-binding sites in
tubulin are not removed by deprivation of the C-terminal regions,
indicating that these sites are distant from the C-terminal regions
(57). Binding of Ca2+ to these low affinity sites may
allosterically regulate the C-terminal region of
-tubulin
responsible for synaptotagmin I binding.
Our findings indicate that tubulin interacts with both C2A and C2B
domains of synaptotagmin I. Like the binding of syntaxin 1A and
phospholipids, the YVK motif in both C2 domains is involved in tubulin
binding. This motif, highly conserved among C2 domain-containing proteins, exists as a part of the
-sheet of C2 domain and is thought
to attract negative charges of binding substances such as syntaxin 1A
and phospholipids (16, 17). Consistent with this notion, the C-terminal
region of
-tubulin is very rich in acidic residues. Their negative
charges are probably important for its binding to the YVK motif. Our
data, together with a previous report (50), show that tubulin, syntaxin
1A, and SNAP-25 bind to similar domains of the synaptotagmin I
molecule. Nevertheless, tubulin does not compete with either syntaxin
1A or SNAP-25 for synaptotagmin I as indicated by the
immunoprecipitation experiments. Presumably, the binding sites of these
three proteins only partially overlap.
The C-terminal portions of both
- and
-tubulins are exposed to
the surface of microtubules (58). The C terminus of
-tubulin binds
MAPs and tau more strongly than that of
-tubulin (52) and regulates
vinblastine-induced tubulin polymerization (59). Thus it probably
regulates assembly and disassembly of tubulins. Usually
Ca2+ inhibits tubulin polymerization directly by high
affinity binding to the C-terminal regions of
- and
-tubulin
(56). However, the present study has shown that synaptotagmin I also
binds to the same region of
-tubulin and promotes tubulin
polymerization in the presence of Ca2+. It has previously
been shown that tubulin dimer deprived of the C-terminal region
of
-tubulin (
s) by digestion with subtilisin is able to polymerize in mM Ca2+ (60). The
removal of the inhibitory effect of Ca2+ on polymerization
is due to the loss of high affinity Ca2+ binding to the
C-terminal region (57). Binding of synaptotagmin I to the C
terminus of
-tubulin may block high affinity Ca2+
binding to the C terminus, allowing tubulin polymerization in high
Ca2+ concentrations.
Microtubules have rarely been observed in the nerve terminal (61). It
is possible that microtubules growing along the axon cease to extend
into the nerve terminal due to inhibition by Ca2+ provided
by influx through voltage-sensitive calcium channels. However, our
findings suggest the possibility that microtubules may be formed and
maintained in the nerve terminal by synaptotagmin I binding to tubulin.
In fact, microtubules have been observed near the active zone by
electron microscopy of the rat brain and the frog neuromuscular
junction under certain conditions of fixation (62, 63) and
immunohistochemically (64). These previous studies have reported
synaptic vesicle association with microtubules in the nerve terminal.
Microtubules that would be formed and stabilized by synaptotagmin
I/tubulin binding might be short-lived due to rapid decline of
Ca2+ concentration in the nerve terminal. Consistent with
this possibility, some structure containing tubulin was transiently
formed near the presynaptic membrane after depolarization of the nerve
terminal at the neuromuscular junction of Drosophila larva
(65). The Ca2+-dependent synaptotagmin
I/tubulin binding found in this study may underlie such transient
structure and be involved in transient retention of synaptic vesicles
near the presynaptic membrane. Further studies are required to
determine whether microtubules or some other tubulin-related structures
are actually formed in the nerve terminal after Ca2+ influx
on depolarization.
Because synaptotagmin I is restricted to synaptic vesicles, our
findings suggest that direct synaptotagmin I/tubulin binding provide a
mechanism for retaining synaptic vesicles on microtubules. Previous
models postulated that the synaptic vesicle pool in the nerve terminal
is formed by attachment of synaptic vesicles to actin fibers through
the binding of synapsin (synaptic vesicle protein) to actin fibers
(66). Recent studies have shown the presence of two distinct pools of
synaptic vesicles in the nerve terminal: readily releasable pool
(exo/endo cycling pool) and reserve pool (67, 68). The former is close
to the active zone, and the latter is distant from the presynaptic
membrane. In synapsin I-deficient mice, the number of synaptic vesicles
distant (150-500 nm) from the active zone was decreased, while neither
the total number of synaptic vesicles nor the number of synaptic
vesicles close (0-150 nm) to the active zone was affected (69, 70). Consistent with this finding, injection of anti-synapsin antibodies into the lampry reticulospinal axon dramatically decreased the number of synaptic vesicles more than 300 nm away from the active zone
(67). These studies suggest the involvement of synapsin in the reserve
pool. Cytochalasin D, an inhibitor of actin polymerization and
depolymerization, eliminated only the reserve pool (68). Therefore, the
interaction between synapsin and actin filaments is important for the
reserve pool but not for the readily releasable pool. What makes up the
readily releasable pool? Our data suggest that synaptotagmin I/tubulin
binding retains synaptic vesicles on microtubules even in high
Ca2+ concentrations. Because of the localization of
voltage-sensitive calcium channels directly involved in
neurotransmitter release in close proximity to the active zone
(71-73), the Ca2+ concentration around the active zone is
expected to become much higher than elsewhere in the nerve terminal
when the channels open. Thus synaptotagmin I/tubulin binding may be
involved in the recovery of synaptic vesicles into the readily
releasable pool after their exocytosis.
Analyses of Drosophila mutants of Stoned proteins that
probably mediate removal of synaptotagmin I from the plasma membrane have revealed a striking decrease in the size of the exo/endo cycling
pool and that synaptotagmin I overexpression restored normal levels of
endocytotic recycling in these mutants (74). Furthermore, synaptotagmin
I overexpression in wild-type flies enhanced synaptic vesicle
endocytosis. These findings indicate a direct, essential role of
synaptotagmin I in the regulation of synaptic vesicle pool and are
consistent with the above possibility that synaptotagmin I is involved
in the regulation of the readily releasable pool. As mentioned above,
synaptic vesicle attachment to microtubules mediated by synaptotagmin
I/tubulin binding in high Ca2+ would be transient due to
rapid removal of Ca2+ within the nerve terminal. Synaptic
vesicles may be transferred quickly from microtubules to some other
structure, which could hold them stably near the presynaptic membrane.
In this study, we have focused on synaptotagmin I, a major form of
synaptotagmin in the brain. As recent studies have indicated that
different synaptotagmins have different localizations and functions, it
will be interesting to examine whether other forms of synaptotagmin
(II-XII) also exhibit similar tubulin binding.
In conclusion, we have demonstrated direct,
Ca2+-dependent, stoichiometric interaction
between the synaptic vesicle protein synaptotagmin I and the
cytoskeletal protein tubulin. This interaction may be involved in the
regulation of synaptic vesicle distribution within the nerve terminal.
 |
ACKNOWLEDGEMENTS |
We thank M. Takahashi for the kind gift of a
mAb to synaptotagmin I.
 |
FOOTNOTES |
*
This work was supported by grants (to T. A.) from the
Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by a Japan Society for the Promotion of
Science Research Fellowship for Young Scientists.
**
To whom correspondence should be addressed. Tel.: 81-25-227-0620;
Fax: 81-25-227-0816; E-mail: teruoa@bri.niigata-u.ac.jp.
Published, JBC Papers in Press, March 29, 2002, DOI 10.1074/jbc.M112080200
 |
ABBREVIATIONS |
The abbreviations used are:
SNARE, soluble
N-ethylmaleimide-sensitive factor attachment protein
receptor;
VAMP, vesicle-associated membrane protein;
AEBSF, 4-(2-aminoethyl)-benzenesulfonyl fluoride;
mAb, monoclonal antibody;
GST, glutathione S-transferase;
Mes, 4-morpholineethanesulfonic acid;
MAPs, microtubule-associated
proteins.
 |
REFERENCES |
| 1.
|
Katz, B.
(1969)
The Release of Neural Transmitter Substances
, Liverpool University Press, Liverpool
|
| 2.
|
Slepnev, V. I.,
and De Camilli, P.
(2000)
Nat. Rev. Neurosci.
1,
161-172[Medline]
[Order article via Infotrieve]
|
| 3.
|
Jarousse, N.,
and Kelly, R. B.
(2001)
Curr. Opin. Cell Biol.
13,
461-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Rothman, J. E.
(1994)
Nature
372,
55-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Augustine, G. J.,
Burns, M. E.,
DeBello, W. M.,
Hilfiker, S.,
Morgan, J. R.,
Schweizer, F. E.,
Tokumaru, H.,
and Umayahara, K.
(1999)
J. Physiol.
520,
33-41[Abstract/Free Full Text]
|
| 6.
|
Jahn, R.,
and Südhof, T. C.
(1999)
Annu. Rev. Biochem.
68,
863-911[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lin, R. C.,
and Scheller, R. H.
(2000)
Annu. Rev. Cell Dev. Biol.
16,
19-49[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Lin, R. C.,
and Scheller, R. H.
(1997)
Neuron
19,
1095-1102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sutton, R. B.,
Fasshauer, D.,
Jahn, R.,
and Brünger, A. T.
(1998)
Nature
395,
347-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Poirier, M. A.,
Xiao, W.,
Macosko, J. C.,
Chan, C.,
Shin, Y. K.,
and Bennett, M. K.
(1998)
Nat. Struct. Biol.
5,
765-769[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Hanson, P. I.,
Roth, R.,
Morisaki, H.,
Jahn, R.,
and Heuser, J. E.
(1997)
Cell
90,
523-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Weber, T.,
Zemelman, B. V.,
McNew, J. A.,
Westermann, B.,
Gmachl, M.,
Parlati, F.,
Söllner, T. H.,
and Rothman, J. E.
(1998)
Cell
92,
759-772[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Schiavo, G.,
Osborne, S. L.,
and Sgouros, J. G.
(1998)
Biochem. Biophys. Res. Commun.
248,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Südhof, T. C.,
and Rizo, J.
(1996)
Neuron
17,
379-388[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Rizo, J.,
and Südhof, T. C.
(1998)
J. Biol. Chem.
273,
15879-15882[Free Full Text]
|
| 16.
|
Davletov, B. A.,
and Südhof, T. C.
(1993)
J. Biol. Chem.
268,
26386-26390[Abstract/Free Full Text]
|
| 17.
|
Chapman, E. R.,
and Jahn, R.
(1994)
J. Biol. Chem.
269,
5735-5741[Abstract/Free Full Text]
|
| 18.
|
Chae, Y. K.,
Abildgaard, F.,
Chapman, E. R.,
and Markley, J. L.
(1998)
J. Biol. Chem.
273,
25659-25663[Abstract/Free Full Text]
|
| 19.
|
Chapman, E. R.,
Hanson, P. I., An, S.,
and Jahn, R.
(1995)
J. Biol. Chem.
270,
23667-23671[Abstract/Free Full Text]
|
| 20.
|
Shao, X., Li, C.,
Fernandez, I.,
Zhang, X.,
Südhof, T. C.,
and Rizo, J.
(1997)
Neuron
18,
133-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Schiavo, G.,
Stenbeck, G.,
Rothman, J. E.,
and Söllner, T. H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
997-1001[Abstract/Free Full Text]
|
| 22.
|
Gerona, R. R. L.,
Larsen, E. C.,
Kowalchyk, J. A.,
and Martin, T. F. J.
(2000)
J.
Biol. Chem.
275,
6328-6336
|
| 23.
|
Augustine, G. J.
(2001)
Curr. Opin. Neurobiol.
11,
320-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Nonet, M. L.,
Grundahl, K.,
Meyer, B. J.,
and Rand, J. B.
(1993)
Cell
73,
1291-1305[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
DiAntonio, A.,
Parfitt, K. D.,
and Schwarz, T. L.
(1993)
Cell
73,
1281-1290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Littleton, J. T.,
Stern, M.,
Schulze, K.,
Perin, M.,
and Bellen, H. J.
(1993)
Cell
74,
1125-1134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Geppert, M.,
Goda, Y.,
Hammer, R, E., Li, C.,
Rosahl, T. W.,
Stevens, C. F.,
and Südhof, T. C.
(1994)
Cell
79,
717-727[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Fernandez-Chacon, R.,
Konigstorfer, A.,
Gerber, S. H.,
Garcia, J.,
Matos, M. F.,
Stevens, C. F.,
Brose, N.,
Rizo, J.,
Rosenmund, C.,
and Südhof, T. C.
(2001)
Nature
410,
41-49[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Davis, A. F.,
Bai, J.,
Fasshauer, D.,
Wolowick, M. J.,
Lewis, J. L.,
and Chapman, E. R.
(1999)
Neuron
24,
363-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Wang, C,-T.,
Grishanin, R.,
Earles, C. A.,
Chang, P. Y.,
Martin, T. F. J.,
Chapman, E. R.,
and Jackson, M. B.
(2001)
Science
294,
1111-1115[Abstract/Free Full Text]
|
| 31.
|
Zhang, J. Z.,
Davletov, B. A.,
Südhof, T. C.,
and Anderson, R. G. W.
(1994)
Cell
78,
751-760[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Haucke, V.,
Wenk, M. R.,
Chapman, E. R.,
Farsad, K.,
and De Camilli, P.
(2000)
EMBO J.
19,
6011-6019[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Jorgensen, E. M.,
Hartwieg, E.,
Schuske, K.,
Nonet, M. L.,
Jin, Y.,
and Horvitz, H. R.
(1995)
Nature
378,
196-199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Littleton, J. T.,
Bai, J.,
Vyas, B.,
Desai, R.,
Baltus, A. E.,
Garment, M. B.,
Carlson, S. D.,
Ganetzky, B.,
and Chapman, E. R.
(2001)
J. Neurosci.
21,
1421-1433[Abstract/Free Full Text]
|
| 35.
|
Fukuda, M.,
Moreira, J. E.,
Lewis, F. M.,
Sugimori, M.,
Niinobu, M.,
Mikoshiba, K.,
and Llinás, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10708-10712[Abstract/Free Full Text]
|
| 36.
|
Morimoto, T.,
Wang, X. H.,
and Poo, M. M.
(1998)
Neuroscience
82,
969-978[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Honda, A.,
Saisu, H.,
Ishizuka, T.,
Mori, K. J.,
and Abe, T.
(1999)
Soc. Neurosci. Abstr.
25,
1742
|
| 38.
|
Honda, A.,
Saisu, H.,
Ishizuka, T.,
Mori, K. J.,
and Abe, T.
(2000)
Soc. Neurosci. Abstr.
26,
347
|
| 39.
|
Ishizuka, T.,
Saisu, H.,
Odani, S.,
Kumanishi, T.,
and Abe, T.
(1999)
Neuroscience
88,
295-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Charvin, N.,
L'eveque, C.,
Walker, D.,
Berton, F.,
Raymond, C.,
Kataoka, M.,
Shoji-Kasai, Y.,
Takahashi, M.,
and Seagar, M. J.
(1997)
EMBO J.
16,
4591-4596[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Higuchi, R.
(1990)
in
PCR Protocols: a Guide to Methods and Applications
(Innis, M. A.
, Gelfand, D. H.
, Sninsky, J. J.
, and White, T. J., eds)
, pp. 177-183, Academic Press, Inc., New York
|
| 42.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Shelanski, M. L.,
Gaskin, F.,
and Cantor, C. R.
(1973)
Proc. Natl. Acad. Sci. U. S. A.
70,
765-768[Abstract/Free Full Text]
|
| 44.
|
Weingarten, M. D.,
Lockwood, A. H.,
Hwo, S. Y.,
and Kirschner, M. W.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
1858-1862[Abstract/Free Full Text]
|
| 45.
|
Rodionov, V. I.,
Gyoeva, F. K.,
Kashina, A. S.,
Kuznetsov, S. A.,
and Gelfand, V. I.
(1990)
J. Biol. Chem.
265,
5702-5707[Abstract/Free Full Text]
|
| 46.
|
Melki, R.,
Kerjan, P.,
Waller, J. P.,
Carlier, M. F.,
and Pantaloni, D.
(1991)
Biochemistry
30,
11536-11545[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Bommert, K.,
Charlton, M. P.,
DeBello, W. M.,
Chin, G. J.,
Betz, H.,
and Augustine, G. J.
(1993)
Nature
363,
163-165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Thomas, D. M.,
and Elferink, L. A.
(1998)
J. Neurosci.
18,
3511-3520[Abstract/Free Full Text]
|
| 49.
|
Desai, R. C.,
Vyas, B.,
Earles, C. A.,
Littleton, J. T.,
Kowalchyk, J. A.,
Martin, T. F. J.,
and Chapman, E. R.
(2000)
J. Cell Biol.
150,
1125-1136[Abstract/Free Full Text]
|
| 50.
|
Earles, C. A.,
Bai, J.,
Wang, P.,
and Chapman, E. R.
(2001)
J. Cell Biol.
154,
1117-1123[Abstract/Free Full Text]
|
| 51.
|
Fujiwara, T.,
Yamamori, T.,
Yamaguchi, K.,
and Akagawa, K.
(1997)
Biochem. Biophys. Res. Commun.
231,
352-355[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Cross, D.,
Dominguez, J.,
Maccioni, R. B.,
and Avila, J.
(1991)
Biochemistry
30,
4362-4366[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Weisenberg, R. C.
(1972)
Science
177,
1104-1105[Abstract/Free Full Text]
|
| 54.
|
Sugita, S.,
Hata, Y.,
and Südhof, T. C.
(1996)
J. Biol. Chem.
271,
1262-1265[Abstract/Free Full Text]
|
| 55.
|
Chapman, E. R., An, S.,
E |